The Long-Term Effects of Cost-Related Nonadherence on COPD Outcomes and Progression in the COPDGene Study Cohort
Policy changes to address out-of-pocket medication costs may improve COPD outcomes and potentially lead to long-term cost savings.
Authors
- Amy L. Non (ORCID: https://orcid.org/0000-0001-9781-2985)
- J. Bailey
- Rajat Suri (ORCID: https://orcid.org/0000-0002-9025-7138)
- Doug Conrad
Institutions
- University of California System (US)
- University of California San Diego (US)
Publication Details
- Journal
- Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
- Published
- 2025-01-01
- DOI
- https://doi.org/10.15326/jcopdf.2025.0689
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- COPD Foundation
- Sunovion
- National Institutes of Health
- Genentech
- National Heart, Lung, and Blood Institute